| (S)-nicotine | multiple interactions | ISO | RGD:733708 | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of EIF2B4 mRNA]; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:733708 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of EIF2B4 mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:733708 | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of EIF2B4 mRNA]; more ... | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:733708 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF2B4 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:733708 | 6480464 | Ethinyl Estradiol results in increased expression of EIF2B4 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733708 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF2B4 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733708 | 6480464 | Tetrachlorodibenzodioxin affects the expression of EIF2B4 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EIF2B4 mRNA | CTD | PMID:21215274 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of EIF2B4 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of EIF2B4 mRNA | CTD | PMID:21346803 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of EIF2B4 mRNA | CTD | PMID:16483693 |
| cadmium dichloride | affects localization | ISO | RGD:733707 | 6480464 | Cadmium Chloride affects the localization of EIF2B4 protein | CTD | PMID:18261755 |
| choline | multiple interactions | ISO | RGD:733708 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EIF2B4 gene | CTD | PMID:20938992 |
| clofibrate | decreases expression | ISO | RGD:733708 | 6480464 | Clofibrate results in decreased expression of EIF2B4 mRNA | CTD | PMID:17585979 |
| copper(2+) sulfate | decreases expression | ISO | RGD:733707 | 6480464 | Copper Sulfate results in decreased expression of EIF2B4 mRNA | CTD | PMID:19549813 |
| dibutyl phthalate | decreases expression | ISO | RGD:733708 | 6480464 | Dibutyl Phthalate results in decreased expression of EIF2B4 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:733708 | 6480464 | Dibutyl Phthalate results in decreased expression of EIF2B4 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of EIF2B4 mRNA | CTD | PMID:21266533 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of EIF2B4 mRNA | CTD | PMID:17920746 |
| folic acid | multiple interactions | ISO | RGD:733708 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EIF2B4 gene | CTD | PMID:20938992 |
| gamma-hexachlorocyclohexane | affects expression | EXP | | 6480464 | Lindane affects the expression of EIF2B4 mRNA | CTD | PMID:22001173 |
| hydrazine | decreases expression | ISO | RGD:733708 | 6480464 | hydrazine results in decreased expression of EIF2B4 mRNA | CTD | PMID:15282401 |
| L-methionine | multiple interactions | ISO | RGD:733708 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EIF2B4 gene | CTD | PMID:20938992 |
| lead(0) | decreases expression | ISO | RGD:733707 | 6480464 | Lead results in decreased expression of EIF2B4 mRNA | CTD | PMID:19921347 |
| nitric oxide | decreases expression | ISO | RGD:733708 | 6480464 | Nitric Oxide deficiency results in decreased expression of EIF2B4 mRNA | CTD | PMID:15878706 |
| paracetamol | affects expression | ISO | RGD:733708 | 6480464 | Acetaminophen affects the expression of EIF2B4 mRNA | CTD | PMID:17562736 |
| resveratrol | increases expression | ISO | RGD:733707 | 6480464 | resveratrol results in increased expression of EIF2B4 mRNA | CTD | PMID:19371625 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases expression | ISO | RGD:733708 | 6480464 | Buthionine Sulfoximine results in decreased expression of EIF2B4 mRNA | CTD | PMID:15878706 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:733707 | 6480464 | tert-Butylhydroperoxide results in increased expression of EIF2B4 mRNA | CTD | PMID:15336504 |
| trans-resveratrol | increases expression | ISO | RGD:733707 | 6480464 | resveratrol results in increased expression of EIF2B4 mRNA | CTD | PMID:19371625 |
| valproic acid | affects expression | ISO | RGD:733708 | 6480464 | Valproic Acid affects the expression of EIF2B4 mRNA | CTD | PMID:17292431 |